Search & Filter

Existing drugs developed for one condition could be repurposed to treat depression, bypassing the discovery phase of drug development, thanks to a new method of studying brain cells, researchers have said.

Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient admissions. It is clear that much of this morbidity relates to poor management, particularly around the use of preventative medicine.

Oral bisphosphonates, such as alendronate, risedronate and etidronate, are the initial therapy advised by NICE for osteoporosis because of their efficacy and cost. They must, however, be taken under a certain set of conditions, which some patients may find difficult to adhere to.

Elderly care home residents with dementia are likely to be prescribed multiple medications, yet this is the group most likely to experience adverse effects as a direct result.

NICE has this month released new quality standards for the management and treatment of the menopause.

This two-part report aims to critically appraise the current evidence for common dietary supplements that have been linked with slowing the progression of, or preventing, Alzheimer's disease (AD).

NICE has published diagnostics guidance recommending that everyone who is diagnosed with colorectal cancer should be tested for an inherited genetic condition called Lynch syndrome

A European-wide study has found that whilst older people with a higher level of education have better memory function, it does not protect them from cognitive decline as they age.

Vifor Pharma has used the 12th ECCO Congress, which took place earlier this month in Barcelona, to highlight the detrimental impact of iron deficiency on an individual's quality of life.

Parkinson's disease is often cared for by hospital specialists. However, falls risk prevention requires a multidisciplinary approach.

New research published has found that patients experiencing age-related macular degeneration are not receiving the information and support needed.

A new report from Age UK has concluded that we are living on borrowed time to save the social care system for older people.

Using postmenopausal oestrogen-based hormone therapy for more than 10 years is associated with a decreased risk of Alzheimer's disease, a large Finnish study has found.

The Phase 3 COMPASS study of rivaroxaban (Xarelto) has been stopped early after meeting its primary endpoint of preventing major adverse cardiac events in patients with coronary artery disease or peripheral artery disease, pharmaceuticals Bayer and Janssen have announced.

The European Commission has approved an update to the label of SGLT2 inhibitor empagliflozin (Jardiance) to include a change to the indication statement, meaning it is now indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise.